Alnylam Pharmaceuticals Inc at Stifel Healthcare Conference Transcript
All right. Thanks, everybody. Super happy to be here doing a panel with 2 executives from Alnylam, Pushkal Garg, Chief Medical Officer; and Jeff Poulton, Chief Financial Officer.
I'm going to have maybe each of these guys just kind of quickly chime in and give a quick snapshot of Alnylam on the pipeline side and then the financial side briefly, and then we will get into, as Pushkal said, the root canal on HELIOS-B. So let's do it. Thank you.
Well, Paul, thanks for having us here today. Really excited to be here with you and the team. Look, I think Alnylam was founded 22 years ago or so. And we couldn't be prouder of the progress we've made. We've basically developed a whole new class of medicines with 5 marketed products that are treating thousands and thousands of patients around the world.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |